We typically think of personalized medicine as involving genomics, but it can utilize any patient specific biomarker. Depression treatment leads to a lot of medical expense. Pharmaceuticals are a primary treatment modality but often the first drug prescribed does not work, which can lead to patients abandoning treatment. (UCLA Release) Researchers at UCLA have now utilized a biomarker which may accelerate identification of drugs which are or aren’t likely to work for a specific patient. The technique involves using EEGs to study brain waves. A pattern of changes from a baseline EEG before treatment and one taken a week after drug use begins can predict the likelihood that the drug will work. While the test obviously involves some expense, it can avoid continued use of a drug which is not providing benefits and associated medical visits. It may also provide quicker improvement in a patient’s condition, which would allow better work and personal life functioning.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Two health care firms owned by private equity firms are merging in a transaction supposedly valued at $3 billion. HealthComp administers self-funded plans for employers and other groups and Virgin...
September 27, 2023
NextGen, an electronic medical records firm, is being put out of its public company misery, as a PE firm will pay $1.6 billion for the one-time high-flier.
September 7, 2023
A number of companies which attracted large financing rounds during the epidemic have imploded when reality set in. The latest is Cano Health, which is a little surprising since it...
August 15, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace